Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isatin–azole hybrids and their anticancer activities
Yani Hou, Congshan Shang, Hui Wang, et al.
Archiv der Pharmazie (2019) Vol. 353, Iss. 1
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules
Pedro Brandão, Carolina S. Marques, Anthony J. Burke, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113102-113102
Open Access | Times Cited: 95
Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations
Wagdy M. Eldehna, Mahmoud A. El Hassab, Mahmoud F. Abo-Ashour, et al.
Bioorganic Chemistry (2021) Vol. 110, pp. 104748-104748
Closed Access | Times Cited: 68
A Mini Review on Pharmacological Significance of Isatin-1,2,3-Triazole Hybrids
Aman Kumar, Yajat Rohila, Vijay Kumar, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 833-847
Closed Access | Times Cited: 21
A survey of isatin hybrids and their biological properties
Vanessa Asoh Shu, Donatus Bekindaka Eni, Fidele Ntie‐Kang
Molecular Diversity (2024)
Open Access | Times Cited: 8
Design, synthesis, biological evaluation and molecular docking of novel isatin-oxime ether derivatives as potential IDH1 inhibitors
Kangning Wei, Kaige Guo, Tao Ye, et al.
Molecular Diversity (2025)
Open Access
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)
Jiaqi Xiao, Meixiang Gao, Zhou Sun, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112830-112830
Closed Access | Times Cited: 56
Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors
Tarfah Al‐Warhi, Ahmed M. El Kerdawy, Nada Aljaeed, et al.
Molecules (2020) Vol. 25, Iss. 9, pp. 2031-2031
Open Access | Times Cited: 51
A Comprehensive Review of the Diverse Spectrum Activity of 1,2,3‐Triazole‐linked Isatin Hybrids
Yajat Rohila, Sharol Sebastian, Azaj Ansari, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 5
Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents
Xiaoyue Wen, Yong-qin Zhou, Junhao Zeng, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 16, pp. 1441-1460
Closed Access | Times Cited: 40
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer
Wagdy M. Eldehna, Rofaida Salem, Zainab M. Elsayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1423-1434
Open Access | Times Cited: 31
A 1,2,3-Triazole Derivative of Quinazoline Exhibits Antitumor Activity by Tethering RNF168 to SQSTM1/P62
Fu-Cheng Wang, Bin Peng, Ting-Ting Ren, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 15028-15047
Closed Access | Times Cited: 22
Zinc Oxide Nanoparticles as Efficient Heterogeneous Catalyst for Synthesis of Bio‐active Heterocyclic Compounds
Gourav Kumar, Vijesh Tomar, Parveen Kumar, et al.
ChemistrySelect (2023) Vol. 8, Iss. 41
Closed Access | Times Cited: 13
Thiazolidinone‐Heterocycle Frameworks: A Concise Review of Their Pharmacological Significance
Pule Seboletswe, Nosipho Cele, Parvesh Singh
ChemMedChem (2023) Vol. 18, Iss. 7
Closed Access | Times Cited: 11
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights
Tarfah Al‐Warhi, Hadia Almahli, Raed M. Maklad, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3203-3203
Open Access | Times Cited: 11
Effects on the magnetic interaction caused by molecular recognition in complexes of 1,2-azole-based oxamate and [Cu(bpca)]+ units
Willian X. C. Oliveira, Carlos B. Pinheiro, Yves Journaux, et al.
CrystEngComm (2024) Vol. 26, Iss. 5, pp. 647-665
Closed Access | Times Cited: 3
Anticancer potential of ferrocene-containing derivatives: Current and future prospective
Vijesh Tomar, Parveen Kumar, Deepak Sharma, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139589-139589
Closed Access | Times Cited: 3
Isatin-derived azoles as new potential antimicrobial agents: Design, synthesis and biological evaluation
Vijai Kumar Reddy Tangadanchu, Yan‐Fei Sui, Cheng‐He Zhou
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 41, pp. 128030-128030
Closed Access | Times Cited: 30
Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity
Min Dong, Guili Zheng, Feng Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Artemisinin-isatin hybrids with potential antiproliferative activity against breast cancer
Yanhua Wang, Ruiqi Ding, Zijian Tai, et al.
Arabian Journal of Chemistry (2021) Vol. 15, Iss. 3, pp. 103639-103639
Open Access | Times Cited: 24
Isatin Counteracts Diethylnitrosamine/2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male Wistar Rats by Upregulating Anti-Inflammatory, Antioxidant, and Detoxification Pathways
Nagwa G. Tawfik, Wafaa R. Mohamed, Hanan S. Mahmoud, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 699-699
Open Access | Times Cited: 17
Antimicrobial evaluation, in silico ADMET prediction, molecular docking, and molecular electrostatic potential of pyrazole-isatin and pyrazole-indole hybrid molecules
Ashraf S. Hassan
Journal of the Iranian Chemical Society (2022) Vol. 19, Iss. 8, pp. 3577-3589
Closed Access | Times Cited: 16
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro
Luiz Saramago, Marcos V. Santana, Bárbara Figueira Gomes, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 9, pp. 2866-2880
Closed Access | Times Cited: 8
A Survey of Isatin Hybrids and their Biological Properties
Vanessa Asoh Shu, Donatus Bekindaka Eni, Fidele Ntie‐Kang
(2024)
Open Access | Times Cited: 2
Tetrazoles: A multi-potent motif in drug design
Ye Yuan, Muzi Li, Vasso Apostolopoulos, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116870-116870
Open Access | Times Cited: 2
Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity
Xinjia Yan, Jing Wen, Lin Zhou, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 21, pp. 1916-1937
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top